Apple Inc. (AAPL) Rises After Reports of Secret Team to Cure Diabetes

Apple Inc. (NASDAQ:AAPL) on April 12 rose by 0.12% in below-average trading to close at 141.80, amid a report from CNBC citing anonymous sources about the tech giant forming a team to cure diabetes.

The secret group, the report said, is a team of biomedical engineers which have been working on sensors to monitor blood sugar levels to better treat diabetes and turn devices like the Apple Watch a must-have.

According to CNBC’s anonymous sources, the company is developing optical sensors, which involves shining a light through the skin to measure indications of glucose.

The efforts have been underway for 5 years and was said to be envisioned by Apple Inc. (NASDAQ:AAPL) co-founder Steve Jobs prior to his death. Jobs envisioned wearable devices to monitor important vitals like oxygen levels, heart rate, and glucose.

CkyBe/Shutterstock.com

What Does The Smart Money Sentiment Say?

The Smart Money was bearish on Apple Inc. (NASDAQ:AAPL) stocks, after we saw a noticeable decline in hedge funds who own shares quarter over quarter. By the end of the fourth quarter of 2016, only 113 hedge funds hold shares of the company valued at $16.54 billion, versus 145 funds who own shares valued at $16.22 billion in the third quarter of the same year.

While the Smart Money shied away from Apple, Warren Buffet of Berkshire Hathaway continues a bullish outlook with a 277% increase in activity in Q4. As of the fourth quarter of 2016, his shares now stand at over 57 million and valued at $6.64 billion.

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 39.7% gains over the past 12 months and outperformed the 24.1% gain enjoyed by the S&P 500 ETFs. Our enhanced small-cap hedge fund strategy returned more than 45% over the last 12 months and outperformed SPY by more than 30 percentage points over the last 4.5 years (see details here).

The Bottom Line

Apple Inc. (NASDAQ:AAPL) shares rose Thursday after a report from CNBC, citing anonymous sources about the tech giant forming a team to cure diabetes. Here are the top 10 best-selling apps for iPhone and iPad.